Solid Preparation Drug - Global and China Top Players Market Share and Ranking 2023

  • According to Ample Market Research, the global market for Solid Preparation Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

    By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Solid Preparation Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Solid Preparation Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

    By segment, Hospital grew percent to account for percent of the total market sales, and Retail Pharmacy grew percent.

    Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.

    This report studies and analyses global Solid Preparation Drug status and future trends, helps the client to determine the Solid Preparation Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Solid Preparation Drug, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.

    For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

    To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

    Highlights

    (1) Global Solid Preparation Drug market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)

    (2) Global Solid Preparation Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

    (3) China Solid Preparation Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

    (4) Global Solid Preparation Drug key consuming regions, consumption quantity, consumption value and demand structure

    (5) Global Solid Preparation Drug key producing regions, capacity, production, and year over year growth

    (6) Solid Preparation Drug industry chains, upstream, midstream and downstream

    Market segment by players, this report covers

    Johnson & Johnson

    Novartis

    Roche

    AbbVie

    Merck & Co.

    Bristol Myers Squibb

    GlaxoSmithKline

    Pfizer

    Sanofi

    Takeda

    AstraZeneca

    Bayer

    Eli Lilly & Co.

    Gilead Sciences

    Amgen

    Teva

    Boehringer Ingelheim

    Biogen

    Astellas

    Market segment by Type, covers

    Tablet

    Capsules

    Other

    Market segment by Application, can be divided into

    Hospital

    Retail Pharmacy

    Other

    Market segment by regions, regional analysis covers

    North America (United States, Canada, and Mexico)

    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

    South America (Brazil, Rest of South America)

    Middle East & Africa

    Report Includes:

    Chapter 1: to describe Solid Preparation Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

    Chapter 2: Global Solid Preparation Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

    Chapter 3: China Solid Preparation Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

    Chapter 4: Global key producing regions of Solid Preparation Drug, percent & CAGR, 2018-2029

    Chapter 5: Solid Preparation Drug industry chain, upstream, medium-stream, and downstream.

    Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

    Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

    Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

    Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

    Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.

    Chapter 11: Conclusions

     

  • With tables and figures helping analyze worldwide Solid Preparation Drug Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


    1 Market Overview

    1.1 Solid Preparation Drug Definition

    1.2 Global Solid Preparation Drug Market Size and Forecast

    1.2.1 By Consumption Value, Global Solid Preparation Drug Market Size,2018-2029
    1.2.2 By Sales Quantity, Global Solid Preparation Drug Market Size,2018-2029
    1.2.3 Global Solid Preparation Drug Average Selling Price (ASP),2018-2029

    1.3 China Solid Preparation Drug Market Size and Forecast

    1.3.1 By Consumption Value, China Solid Preparation Drug Market Size,2018-2029
    1.3.2 By Sales Quantity, China Solid Preparation Drug Market Size,2018-2029
    1.3.3 China Solid Preparation Drug Average Selling Price (ASP), 2018-2029

    1.4 Share of China Solid Preparation Drug Market with Respect to the Global Market

    1.4.1 By Consumption Value, China Solid Preparation Drug Market Share in Global, 2018-2029
    1.4.2 By Sales Quantity, China Solid Preparation Drug Market Share in Global, 2018-2029
    1.4.3 Solid Preparation Drug Market Size: China VS Global, 2018-2029

    1.5 Solid Preparation Drug Market Dynamics

    1.5.1 Solid Preparation Drug Market Drivers
    1.5.2 Solid Preparation Drug Market Restraints
    1.5.3 Solid Preparation Drug Industry Trends
    1.5.4 Solid Preparation Drug Industry Policy

    2 Global Leading Manufacturers and Market Share

    2.1 By Revenue of Solid Preparation Drug, Global Market Share by Company, 2018-2023

    2.2 By Sales Quantity of Solid Preparation Drug, Global Market Share by Company, 2018-2023

    2.3 Solid Preparation Drug Average Selling Price (ASP) by Company, 2018-2023

    2.4 Global Solid Preparation Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)

    2.5 Global Solid Preparation Drug Concentration Ratio

    2.6 Global Solid Preparation Drug Mergers & Acquisitions, Expansion Plans

    2.7 Global Solid Preparation Drug Manufacturers Product Type
    2.8 Head Office and Solid Preparation Drug Production Site of Key Manufacturer
    2.9 Solid Preparation Drug Capacity of Major Manufacturers and Future Plan

    3 China Leading Manufacturers and Market Share

    3.1 By Revenue of Solid Preparation Drug, China Market Share by Company, 2018-2023

    3.2 By Sales Quantity of Solid Preparation Drug, China Market Share by Company, 2018-2023

    3.3 China Solid Preparation Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)


    4 Global Producing Regions

    4.1 Global Solid Preparation Drug Capacity, Output and Capacity Utilization, 2018-2029

    4.2 Global Solid Preparation Drug Capacity by Region

    4.3 Global Solid Preparation Drug Production & Forecast by Region, 2018 VS 2022 VS 2029

    4.4 Global Solid Preparation Drug Production by Region, 2018-2029

    4.5 Global Solid Preparation Drug Production Market Share & Forecast by Region, 2018-2029


    5 Industry Chain Analysis

    5.1 Solid Preparation Drug Industry Chain

    5.2 Solid Preparation Drug Upstream Analysis

    5.2.1 Solid Preparation Drug Core Raw Materials
    5.2.2 Main Manufacturers of Solid Preparation Drug Core Raw Materials

    5.3 Midstream Analysis

    5.4 Downstream Analysis

    5.5 Solid Preparation Drug Production Mode

    5.6 Solid Preparation Drug Procurement Model

    5.7 Solid Preparation Drug Industry Sales Model and Sales Channels
    5.7.1 Solid Preparation Drug Sales Model
    5.7.2 Solid Preparation Drug Typical Distributors

    6 Sights by Type

    6.1 Solid Preparation Drug Classification

    6.1.1 Tablet
    6.1.2 Capsules
    6.1.3 Other

    6.2 By Type, Global Solid Preparation Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029

    6.3 By Type, Global Solid Preparation Drug Consumption Value, 2018-2029

    6.4 By Type, Global Solid Preparation Drug Sales Quantity, 2018-2029

    6.5 By Type, Global Solid Preparation Drug Average Selling Price (ASP), 2018-2029


    7 Sights by Application

    7.1 Solid Preparation Drug Segment by Application

    7.1.1 Hospital
    7.1.2 Retail Pharmacy
    7.1.3 Other

    7.2 By Application, Global Solid Preparation Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029

    7.3 By Application, Global Solid Preparation Drug Consumption Value, 2018-2029

    7.4 By Application, Global Solid Preparation Drug Sales Quantity, 2018-2029

    7.5 By Application, Global Solid Preparation Drug Price, 2018-2029


    8 Sales Sights by Region

    8.1 By Region, Global Solid Preparation Drug Consumption Value, 2018 VS 2022 VS 2029

    8.2 By Region, Global Solid Preparation Drug Consumption Value, 2018-2029

    8.3 By Region, Global Solid Preparation Drug Sales Quantity, 2018-2029

    8.4 North America

    8.4.1 North America Solid Preparation Drug & Forecasts, 2018-2029
    8.4.2 By Country, North America Solid Preparation Drug Market Size Market Share

    8.5 Europe

    8.5.1 Europe Solid Preparation Drug Market Size & Forecasts, 2018-2029
    8.5.2 By Country, Europe Solid Preparation Drug Market Size Market Share

    8.6 Asia Pacific

    8.6.1 Asia Pacific Solid Preparation Drug Market Size & Forecasts, 2018-2029
    8.6.2 By Country/Region, Asia Pacific Solid Preparation Drug Market Size Market Share
    8.7 South America
    8.7.1 South America Solid Preparation Drug Market Size & Forecasts, 2018-2029
    8.7.2 By Country, South America Solid Preparation Drug Market Size Market Share
    8.8 Middle East & Africa

    9 Sales Sights by Country Level

    9.1 By Country, Global Solid Preparation Drug Market Size & CAGR, 2018 VS 2022 VS 2029

    9.2 By Country, Global Solid Preparation Drug Consumption Value, 2018-2029

    9.3 By Country, Global Solid Preparation Drug Sales Quantity, 2018-2029

    9.4 U.S.

    9.4.1 U.S. Solid Preparation Drug Market Size, 2018-2029
    9.4.2 By Type, U.S. Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.4.3 By Application, U.S. Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029

    9.5 Europe

    9.5.1 Europe Solid Preparation Drug Market Size, 2018-2029
    9.5.2 By Type, Europe Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.5.3 By Application, Europe Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029

    9.6 China

    9.6.1 China Solid Preparation Drug Market Size, 2018-2029
    9.6.2 By Type, China Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.6.3 By Application, China Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.7 Japan
    9.7.1 Japan Solid Preparation Drug Market Size, 2018-2029
    9.7.2 By Type, Japan Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.7.3 By Application, Japan Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.8 South Korea
    9.8.1 South Korea Solid Preparation Drug Market Size, 2018-2029
    9.8.2 By Type, South Korea Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.8.3 By Application, South Korea Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.9 Southeast Asia
    9.9.1 Southeast Asia Solid Preparation Drug Market Size, 2018-2029
    9.9.2 By Type, Southeast Asia Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.9.3 By Application, Southeast Asia Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029

    9.10 India

    9.10.1 India Solid Preparation Drug Market Size, 2018-2029
    9.10.2 By Type, India Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.10.3 By Application, India Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.11 Middle East & Africa
    9.11.1 Middle East & Africa Solid Preparation Drug Market Size, 2018-2029
    9.11.2 By Type, Middle East & Africa Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029
    9.11.3 By Application, Middle East & Africa Solid Preparation Drug Sales Quantity Market Share, 2022 VS 2029

    10 Manufacturers Profile

    10.1 Johnson & Johnson

    10.1.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
    10.1.2 Johnson & Johnson Solid Preparation Drug Models, Specifications, and Application
    10.1.3 Johnson & Johnson Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.1.4 Johnson & Johnson Company Profile and Main Business
    10.1.5 Johnson & Johnson Recent Developments

    10.2 Novartis

    10.2.1 Novartis Company Information, Head Office, Market Area, and Industry Position
    10.2.2 Novartis Solid Preparation Drug Models, Specifications, and Application
    10.2.3 Novartis Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.2.4 Novartis Company Profile and Main Business
    10.2.5 Novartis Recent Developments

    10.3 Roche

    10.3.1 Roche Company Information, Head Office, Market Area, and Industry Position
    10.3.2 Roche Solid Preparation Drug Models, Specifications, and Application
    10.3.3 Roche Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.3.4 Roche Company Profile and Main Business
    10.3.5 Roche Recent Developments

    10.4 AbbVie

    10.4.1 AbbVie Company Information, Head Office, Market Area, and Industry Position
    10.4.2 AbbVie Solid Preparation Drug Models, Specifications, and Application
    10.4.3 AbbVie Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.4.4 AbbVie Company Profile and Main Business
    10.4.5 AbbVie Recent Developments

    10.5 Merck & Co.

    10.5.1 Merck & Co. Company Information, Head Office, Market Area, and Industry Position
    10.5.2 Merck & Co. Solid Preparation Drug Models, Specifications, and Application
    10.5.3 Merck & Co. Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.5.4 Merck & Co. Company Profile and Main Business
    10.5.5 Merck & Co. Recent Developments

    10.6 Bristol Myers Squibb

    10.6.1 Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
    10.6.2 Bristol Myers Squibb Solid Preparation Drug Models, Specifications, and Application
    10.6.3 Bristol Myers Squibb Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.6.4 Bristol Myers Squibb Company Profile and Main Business
    10.6.5 Bristol Myers Squibb Recent Developments
    10.7 GlaxoSmithKline
    10.7.1 GlaxoSmithKline Company Information, Head Office, Market Area, and Industry Position
    10.7.2 GlaxoSmithKline Solid Preparation Drug Models, Specifications, and Application
    10.7.3 GlaxoSmithKline Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.7.4 GlaxoSmithKline Company Profile and Main Business
    10.7.5 GlaxoSmithKline Recent Developments
    10.8 Pfizer
    10.8.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
    10.8.2 Pfizer Solid Preparation Drug Models, Specifications, and Application
    10.8.3 Pfizer Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.8.4 Pfizer Company Profile and Main Business
    10.8.5 Pfizer Recent Developments
    10.9 Sanofi
    10.9.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
    10.9.2 Sanofi Solid Preparation Drug Models, Specifications, and Application
    10.9.3 Sanofi Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.9.4 Sanofi Company Profile and Main Business
    10.9.5 Sanofi Recent Developments

    10.10 Takeda

    10.10.1 Takeda Company Information, Head Office, Market Area, and Industry Position
    10.10.2 Takeda Solid Preparation Drug Models, Specifications, and Application
    10.10.3 Takeda Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.10.4 Takeda Company Profile and Main Business
    10.10.5 Takeda Recent Developments
    10.11 AstraZeneca
    10.11.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
    10.11.2 AstraZeneca Solid Preparation Drug Models, Specifications, and Application
    10.11.3 AstraZeneca Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.11.4 AstraZeneca Company Profile and Main Business
    10.11.5 AstraZeneca Recent Developments
    10.12 Bayer
    10.12.1 Bayer Company Information, Head Office, Market Area, and Industry Position
    10.12.2 Bayer Solid Preparation Drug Models, Specifications, and Application
    10.12.3 Bayer Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.12.4 Bayer Company Profile and Main Business
    10.12.5 Bayer Recent Developments
    10.13 Eli Lilly & Co.
    10.13.1 Eli Lilly & Co. Company Information, Head Office, Market Area, and Industry Position
    10.13.2 Eli Lilly & Co. Solid Preparation Drug Models, Specifications, and Application
    10.13.3 Eli Lilly & Co. Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.13.4 Eli Lilly & Co. Company Profile and Main Business
    10.13.5 Eli Lilly & Co. Recent Developments
    10.14 Gilead Sciences
    10.14.1 Gilead Sciences Company Information, Head Office, Market Area, and Industry Position
    10.14.2 Gilead Sciences Solid Preparation Drug Models, Specifications, and Application
    10.14.3 Gilead Sciences Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.14.4 Gilead Sciences Company Profile and Main Business
    10.14.5 Gilead Sciences Recent Developments
    10.15 Amgen
    10.15.1 Amgen Company Information, Head Office, Market Area, and Industry Position
    10.15.2 Amgen Solid Preparation Drug Models, Specifications, and Application
    10.15.3 Amgen Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.15.4 Amgen Company Profile and Main Business
    10.15.5 Amgen Recent Developments
    10.16 Teva
    10.16.1 Teva Company Information, Head Office, Market Area, and Industry Position
    10.16.2 Teva Solid Preparation Drug Models, Specifications, and Application
    10.16.3 Teva Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.16.4 Teva Company Profile and Main Business
    10.16.5 Teva Recent Developments
    10.17 Boehringer Ingelheim
    10.17.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
    10.17.2 Boehringer Ingelheim Solid Preparation Drug Models, Specifications, and Application
    10.17.3 Boehringer Ingelheim Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.17.4 Boehringer Ingelheim Company Profile and Main Business
    10.17.5 Boehringer Ingelheim Recent Developments
    10.18 Biogen
    10.18.1 Biogen Company Information, Head Office, Market Area, and Industry Position
    10.18.2 Biogen Solid Preparation Drug Models, Specifications, and Application
    10.18.3 Biogen Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.18.4 Biogen Company Profile and Main Business
    10.18.5 Biogen Recent Developments
    10.19 Astellas
    10.19.1 Astellas Company Information, Head Office, Market Area, and Industry Position
    10.19.2 Astellas Solid Preparation Drug Models, Specifications, and Application
    10.19.3 Astellas Solid Preparation Drug Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
    10.19.4 Astellas Company Profile and Main Business
    10.19.5 Astellas Recent Developments

    11 Conclusion

    12 Appendix

    12.1 Research Methodology

    12.2 Data Source

    12.2.1 Secondary Sources
    12.2.2 Primary Sources

    12.3 Market Estimation Model

    12.4 Disclaimer

     

  • The Solid Preparation Drug Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
      By Regions:
        By Type:
          By Application:
          Frequently asked questions(FAQ's):
          Is the Solid Preparation Drug Global and China Top Players Market shifting its focus from growth to value?

          Recognize the areas along the Solid Preparation Drug Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.

          What are the major applications for Solid Preparation Drug Global and China Top Players?

          Solid Preparation Drug Global and China Top Players has a wide range of applications, including and others.

          What is the forecasted growth rate of the Solid Preparation Drug Global and China Top Players Market?

          The Solid Preparation Drug Global and China Top Players Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.

          What challenges does the Solid Preparation Drug Global and China Top Players Market face in the future?

          The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Solid Preparation Drug Global and China Top Players Market across the extensive corporate landscape.

          How is the competitive landscape for the Solid Preparation Drug Global and China Top Players Market defined?

          Companies in the Solid Preparation Drug Global and China Top Players Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Solid Preparation Drug Global and China Top Players Market's trajectory and future outlook.

          Our Clients